Surface Oncology to Participate in the Baird 2022 Global Healthcare Conference

September 7, 2022

https://www.globenewswire.com/news-release/2022/09/07/2512009/0/en/Surface-Oncology-to-Participate-in-the-Baird-2022-Global-Healthcare-Conference.html

CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Wednesday, September 14, 2022, at 10:15 a.m. ET.

Read more at globenewswire.com

Related news for (SURF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.